AQXP Shares Outstanding History
Below is a table of the AQXP shares outstanding history going back to 3/6/2014:

Date AQXP Shares Outstanding
3/6/20149.55M
4/30/201410.68M
8/7/201410.70M
11/3/201410.70M
3/12/201510.72M
5/4/201510.72M
8/5/201510.73M
11/9/201517.21M
3/10/201617.21M
5/9/201617.21M
8/4/201617.21M
11/9/201623.42M
3/9/201723.42M
5/9/201723.42M
8/8/201723.46M
11/8/201723.46M
3/9/201823.49M
5/8/201823.51M
8/8/201823.54M
11/7/201823.54M
3/7/201923.54M
4/15/201923.54M
5/7/201923.54M
8/1/201923.54M

Also see: AQXP Market Cap History
AQXP YTD Return
AQXP Historical Shares Outstanding:
+18.17% CAGR
AQXP Historical Shares Outstanding: +18.17% CAGR

Mouse over chart for data details
3/6/2014 ...8/1/2019
Aquinox Pharmaceuticals is a clinical-stage pharmaceutical company discovering and developing therapeutics for chronic urological conditions marked by inflammation and pain. Co.'s primary drug candidate, rosiptor, for the treatment of patients with interstitial cystitis/bladder pain syndrome (IC/BPS). Co. is focused on utilizing its library of novel compounds that activate SHIP1 (SH2-containing inositol-5'-phosphatase to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. We show 24 historical shares outstanding datapoints in our coverage of AQXP's shares outstanding history.

Understanding the changing numbers of AQXP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AQXP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AQXP by allowing them to research AQXP shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AQXP:
AQXP SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aquinox Pharmaceuticals (AQXP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ARA Shares Outstanding History
ARAY Shares Outstanding History
ARDM Shares Outstanding History
ARDX Shares Outstanding History
ARNA Shares Outstanding History
ARQL Shares Outstanding History
ARRY Shares Outstanding History
ARWR Shares Outstanding History
ASMB Shares Outstanding History
ASNS Shares Outstanding History
More Healthcare companies »

 

AQXP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.